These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. Ding C; Li L; Yang T; Fan X; Wu G BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020 [TBL] [Abstract][Full Text] [Related]
4. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy. Seeber A; Gunsilius E; Gastl G; Pircher A Oncol Res Treat; 2018; 41(4):188-193. PubMed ID: 29562227 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model. Mueller T; Freystein J; Lucas H; Schmoll HJ Molecules; 2019 Aug; 24(16):. PubMed ID: 31394786 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms. Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916 [TBL] [Abstract][Full Text] [Related]
7. Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways. Shen A; Lin J; Chen Y; Lin W; Liu L; Hong Z; Sferra TJ; Peng J Oncol Rep; 2013 Oct; 30(4):1701-6. PubMed ID: 23843018 [TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer. Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Ellis LM; Takahashi Y; Liu W; Shaheen RM Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer. Garona J; Sobol NT; Pifano M; Segatori VI; Gomez DE; Ripoll GV; Alonso DF Cancer Res Treat; 2019 Apr; 51(2):438-450. PubMed ID: 29879760 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and its role in colorectal tumor and metastasis formation. Ellis LM Semin Oncol; 2004 Dec; 31(6 Suppl 17):3-9. PubMed ID: 15696024 [TBL] [Abstract][Full Text] [Related]
13. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432 [TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
15. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Frumovitz M; Sood AK Gynecol Oncol; 2007 Mar; 104(3):768-78. PubMed ID: 17306693 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907 [TBL] [Abstract][Full Text] [Related]
18. [Liver metastasis in colorectal cancer and tumor angiogenesis]. Xie Z; Huang X; Li J; Zhou L Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):336-7, 21. PubMed ID: 11829853 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor as a target for anticancer therapy. Ferrara N Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810 [TBL] [Abstract][Full Text] [Related]
20. The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer. Fakih M Expert Rev Anticancer Ther; 2013 Apr; 13(4):427-38. PubMed ID: 23432698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]